M&A and equity raisings

6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

US deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

12 deals · US$1.8bndisclosed · Pharmaceutical Manufacturing · Clear

Columns
M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Sep 2026 portfolio of 20 mature medicines and three manufacturing sites SanofiCheplapharmAsset saleAnnounced–Pharma+1 Freshfields (sell-side)Latham & Watkins (buy-side)
Jul 2026 PolyPeptide Group AG –Samsung Biologics Co.AcquisitionAnnounced1,454.0Pharma Services+2 J.P. Morgan (buy-side)EY (buy-side)O'Melveny & Myers (buy-side)Schellenberg Wittmer (buy-side)
Jul 2026 Lannett –AurobindoAcquisitionCompleted250.0Pharma+1 Raymond JamesSullivan & Cromwell (buy-side)
Jul 2026 InfoRLife SA Sergio DusciBC PartnersStakeAnnounced–Pharma Services+1 Latham & Watkins (buy-side)
May 2026 AmbioPharm –CordenPharmaAcquisitionAnnounced–Pharma Services+2 Kirkland & EllisBNP Paribas (sell-side)Latham & Watkins (buy-side)
May 2026 MacroGenics GMP manufacturing site and CDMO operations MacroGenicsBora Pharmaceuticals Co.Asset saleCompleted122.5Pharmaceutical Manufacturing+1 Moelis & Company (sell-side)Sidley Austin (sell-side)Covington & Burling (sell-side)Jones Day (buy-side)
Mar 2026 Lonza Capsules & Health Ingredients division Lonza Group AGLone Star FundsAsset saleAnnounced–Pharmaceutical Manufacturing+2 Kirkland & Ellis (buy-side)
Mar 2026 Manufacturing facility in Phoenix, AZ Bristol Myers SquibbRoviAsset saleCompleted–Pharmaceutical Manufacturing+1 William Blair
Jan 2026 Nivagen Pharmaceuticals –PAI PharmaAcquisitionAnnounced–Pharmaceutical Manufacturing+1 Bourne Partners (buy-side)Kirkland & Ellis (buy-side)KPMG (buy-side)
2026 Istituto Biochimico Italiano Giovanni Lorenzini (IBI Lorenzini) –ACS DobfarAcquisitionAnnounced–Pharmaceutical Manufacturing+1 Lincoln International (sell-side)
Sep 2025 Zentiva Advent InternationalGTCRAcquisitionAnnounced–Pharma+1 Goldman Sachs (sell-side)PJT Partners (sell-side)Freshfields (sell-side)Barclays (buy-side)BNP Paribas (buy-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side)
Jun 2025 Felix Pharmaceuticals Pvt –Advent InternationalStakeAnnounced–Animal Health+2 A&L Goodbody LLPLincoln International (sell-side)Guggenheim Securities (buy-side)

Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.